Manufacturer record
Apple Formulations Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
49 batches manufactured by Apple Formulations Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between April 2020 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
49 records linked to Apple Formulations Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
0Banned or prohibited
0Recalled or suspended
49Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
49
NSQ batches since 2020
26
Products affected
pH
Most common failure
Jul 2026
Latest alert
Flagged batches per year
2020 · 32022 · 92023 · 112024 · 22025 · 172026 · 7
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ofloxacin Metronidazole and Simethicone Suspension | OXG2501Mfg 2025-09 · Exp 2027-08 | Content of Metronidazole (45.68%)Other | Drugs Testing Laboratory, Madurai-19State lab | Jul 2026 |
| Glimepiride Tablets IP 1mg | GTA-2501Mfg 2025-01 · Exp 2027-01 | The sample does not conform to standard quality in respect of the test for ?Description? performed.Description | SDTL, Tripura, AgartalaState lab | Jul 2026 |
| Sucralfate & Oxetacaine Suspension | SCI-2508Mfg 2025-12 · Exp 2027-11 | ContentOther | DTL, Madurai-19State lab | Jun 2026 |
| Cetirizine Syrup IP | CIZ-2604Mfg 2026-03 · Exp 2028-02 | pHpH | SDTL, PunjabState lab | Jun 2026 |
| Levocetrizine Dihydrochloride Tablets IP) | LEE-2501Mfg 2025-06 · Exp 2027-05 | The sample does not conform to standard in respect of the test for Description performed.Description | SDTL,Govt. of Tripura, AgartalaState lab | May 2026 |
| Amlodipine Besylate Tablets IP | AML-2506Mfg 2025-12 · Exp 2027-11 | The sample received does not conform to I.P. 2022 with respect to the test for Related substances. other test could not be done due to technical reason.Related substances | CDTL, MumbaiCDSCO lab | May 2026 |
| Ondansetron Orally Disintegrating Tablets IP 4 mg | OSD-2501Mfg 2025-11 · Exp 2027-10 | The sample does not conform to I.P.w.r.t. the tests for AssayAssay | SDTL, AssamState lab | Mar 2026 |
| Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup (Ambroflex-LS Syrup ) | AFG-2502Mfg 2025-05 · Exp 2027-04 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Dec 2025 |
| Dextromethorphan Hydrobromide, Chlorpheniramine Maleate, Phenylephrine Hydrochloride Syrup(Caredex Junior ) | CXR-2502Mfg 2025-06 · Exp 2027-05 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Dec 2025 |
| Ambroxol Hydrochloride. Levosalbutamol Sulphate and Guaiphenesin syrup (Brokuff LS Junior Syrup ) | BKJ-2503Mfg 2025-04 · Exp 2027-03 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Dec 2025 |
| Albendazole Tablets IP 400 mg | AAO-2502Mfg 2025-04 · Exp 2027-03 | Assay (Albendazole)Assay | SDTL, GuwahatiState lab | Dec 2025 |
| Sucralfate & Oxetacaine Suspension | SCO-2503Mfg 2025-06 · Exp 2027-05 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Nov 2025 |
| Azithromycin Tablets IP 500 mg. | AYC-2407Mfg 2024-01 · Exp 2025-12 | The sample does not comply as per I.P. 2022 with respect to the test for "Dissolution" of Azithromycin.Dissolution | RDTL, GuwahatiCDSCO lab | Nov 2025 |
| Ambroxol Hydrochloride 15mg, Terbutaline Sulphate 1.25 mg, Guaiphenesin 50 mg, Menthol 0.5 mg (NUREX-AP ) | NRA-2403Mfg 2024-12 · Exp 2026-11 | Assay of Ambroxol HCl (81.53%) & Terbutaline Sulphate (74.40 %)Assay | DTL Baddi H.PState lab | Oct 2025 |
| Ofloxacin & Ornidazole Tablets I.P.. | OZH-2501Mfg 2025-04 · Exp 2027-03 | sample does not comply as per I.P. 2022 with respect to the test for "Dissolution" of Ofloxacin and Ornidazole.Dissolution | RDTL, GuwahatiCDSCO lab | Sep 2025 |
| Miconazole Nitrate Cream IP 2% w/w | MZP-2502Mfg 2025-08 · Exp 2027-07 | AssayAssay | SDTL, PunjabState lab | Sep 2025 |
| Cholecalciferol (Vitamin D3) Oral Solution USP 400 IU/ml | VAM-2501Mfg 2025-06 · Exp 2026-11 | The Product is not labeled in the prescribed manner as per USP monographLabelling | State Drugs Laboratory, PunjabState lab | Aug 2025 |
| Azithromycin Tablets IP 500 mg. | AYC-2407Mfg 2024-01 · Exp 2025-12 | Dissolution of AzithromycinDissolution | RDTL GuwahatiCDSCO lab | Jun 2025 |
| Vitamin B1, Vitamin B2, Nicotinamide, Vitamin B6, Vitamin B12 & Calcium D-Pantothenate Syrup (B-Complex Syrup) | BOB-2440Mfg 2024-06 · Exp 2025-11 | Assay of Vitamin B12Assay | CDL, KolkataCDSCO lab | Mar 2025 |
| Vitamin B1, Vitamin B2, Nicotinamide, Vitamin B6, Vitamin B12 & Calcium D-Pantothenate Syrup (B-Complex Syrup) | BOB-2451Mfg 2024-06 · Exp 2025-11 | Total aerobic viable count under Microbial limit testMicrobial limits | CDL, KolkataCDSCO lab | Mar 2025 |
| Vitamin B1, Vitamin B2, Nicotinamide, Vitamin B6, Vitamin B12 & Calcium D- Pantothenate Syrup (B- Complex Syrup) | BOB-2424Mfg 2024-06 · Exp 2025-11 | Assay of Calcium D-PantothenateAssay | CDL KolkataCDSCO lab | Feb 2025 |
| Vitamin B1, Vitamin B2, Nicotinamide, Vitamin B6, Vitamin B12 & Calcium D- Pantothenate Syrup (B- Complex Syrup), | BOB-2423Mfg 2024-06 · Exp 2025-11 | Assay of Calcium D-PantothenateAssay | CDL KolkataCDSCO lab | Feb 2025 |
| Vitamin B1, Vitamin B2, Nicotinamide, Vitamin B6, Vitamin B12 & Calcium D- Pantothenate Syrup (B- Complex Syrup) | BOB-2438Mfg 2024-06 · Exp 2025-11 | Assay of Vitamin B12Assay | CDL KolkataCDSCO lab | Feb 2025 |
| Sucnol-O Suspension | SCI-2305Mfg 2023-11 · Exp 2025-10 | Sample does not conform to Label Claim with respect to the content of OxetacaineLabelling | DTL MaduraiState lab | Jan 2025 |
| Etoricoxib Tablets I.P. 90 mg. | ECX-2304Mfg 2023-08 · Exp 2025-07 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Jun 2024 |
| GLIMEPIRIDE TABLETS I.P. 1 mg. | GLT-2301Mfg 2023-01 · Exp 2024-12 | DissolutionDissolution | RDTL GuwahatiState lab | Jan 2024 |
| GLIMEPIRIDE TABLETS I.P. 1 mg. | GLT-2301Mfg 2023-01 · Exp 2024-12 | DissolutionDissolution | RDTL GuwahatiState lab | Nov 2023 |
| Rabeprazole Sodium (Enteric Coated) and Domperidone (Sustained Release) Capsules (20 mg/30 mg) | RPE-2258Mfg 2022-07 · Exp 2024-06 | Assay of Rabeprazole SodiumAssay | RDTL ChandigarhCDSCO lab | Jul 2023 |
| Glimkar-4 (Glimepiride Tablets 4 mg) | GKR-2210Mfg 2022-04 · Exp 2024-03 | DissolutionDissolution | CDL KolkataCDSCO lab | Jun 2023 |
| Levocetirizine Dihydrochloride Syrup., 30ml | LZR-2202Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Feb 2023 |
| Levocetirizine Dihydrochloride Syrup., 30ml | LZR-2204Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Feb 2023 |
| Levocetirizine Dihydrochloride Syrup | LZR-2203Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Feb 2023 |
| Zinc Sulphate Oral Solution I.P., 100ml | ZCH-2207Mfg 2022-01 · Exp 2023-12 | Weight per mlWeight | RDTL GuwahatiState lab | Jan 2023 |
| Zinc Sulphate Oral Solution I.P., 100 ml | ZCH-2209Mfg 2022-01 · Exp 2023-12 | Weight per mlWeight | RDTL GuwahatiState lab | Jan 2023 |
| Levocetirizine Dihydrochloride Syrup 30 ml | LZR-2209Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Jan 2023 |
| Levocetirizine Dihydrochloride Syrup 30 ml | LZR-2207Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Jan 2023 |
| Levocetirizine Dihydrochloride Syrup 30 ml | LZR-2211Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Jan 2023 |
| Levocetirizine Dihydrochloride Syrup, 30ml | LZR-2204Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Dec 2022 |
| Levocetirizine Dihydrochloride Syrup | LZR-2204Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Dec 2022 |
| Levocetirizine Dihydrochloride Syrup | LZR-2208Mfg 2022-01 · Exp 2023-12 | ?pH?pH | RDTL GuwahatiState lab | Dec 2022 |
| Levocetirizine Dihydrochloride Syrup. 30 ml | LZR-2202Mfg 2022-01 · Exp 2023-12 | ?pH?pH | RDTL GuwahatiState lab | Nov 2022 |
| Levocetirizine Dihydrochloride Syrup (30 ml) | LZR-2207Mfg 2022-01 · Exp 2023-12 | ?pH?pH | RDTL GuwahatiState lab | Nov 2022 |
| Levocetirizine Dihydrochloride Syrup | LZR-2204Mfg 2022-01 · Exp 2023-12 | ?pH?pH | RDTL GuwahatiState lab | Nov 2022 |
| Levocetirizine Dihydrochloride Syrup | LZR-2202Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Sep 2022 |
| Azithromycin Oral Suspension IP 200 mg/ 5 ml | AYA-2101Mfg 2021-01 · Exp 2022-12 | Assay/content of Anhydrous AzithromycinAssay | RDTL GuwahatiState lab | Sep 2022 |
| Levocetirizine Dihydrochloride Tablets IP 5 mg | LCL-2105Mfg 2021-07 · Exp 2023-06 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2022 |
| Paracetamol Paediatric oral Suspension IP (Parawin ?DS Suspension) | PWS-1905Mfg 2019-12 · Exp 2021-11 | Related SubstancesRelated substances | RDTL ChandigarhCDSCO lab | Nov 2020 |
| Alumina, Magnesia & Simethicone Oral Suspension IP | AME-1901Mfg 2019-04 · Exp 2021-03 | Assay of DimethiconeAssay | CDTL MumbaiCDSCO lab | Apr 2020 |
| Alumina, Magnesia & Simethicone Oral Suspension IP | AME-1902Mfg 2019-04 · Exp 2021-03 | Assay of DimethiconeAssay | CDTL MumbaiCDSCO lab | Apr 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.